RY

169.6

+0.19%↑

TD

94.61

+0.7%↑

BMO

133.35

+0.79%↑

BNS

72.88

+1.19%↑

CM

91.72

+0.26%↑

RY

169.6

+0.19%↑

TD

94.61

+0.7%↑

BMO

133.35

+0.79%↑

BNS

72.88

+1.19%↑

CM

91.72

+0.26%↑

RY

169.6

+0.19%↑

TD

94.61

+0.7%↑

BMO

133.35

+0.79%↑

BNS

72.88

+1.19%↑

CM

91.72

+0.26%↑

RY

169.6

+0.19%↑

TD

94.61

+0.7%↑

BMO

133.35

+0.79%↑

BNS

72.88

+1.19%↑

CM

91.72

+0.26%↑

RY

169.6

+0.19%↑

TD

94.61

+0.7%↑

BMO

133.35

+0.79%↑

BNS

72.88

+1.19%↑

CM

91.72

+0.26%↑

Search

Main Street Capital Corp

Chiusa

SettoreFinanza

62.02 2.11

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

60.4

Massimo

62.61

Metriche Chiave

By Trading Economics

Entrata

176M

124M

Vendite

-19M

184M

P/E

Media del settore

10.219

26.043

Rendimento da dividendi

4.86

Margine di Profitto

67.32

Dipendenti

104

EBITDA

-26M

133M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+7.54% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.86%

4.04%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

482M

5.6B

Apertura precedente

59.91

Chiusura precedente

62.02

Notizie sul Sentiment di mercato

By Acuity

50%

50%

182 / 525 Classifica in Finance

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Main Street Capital Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2026, 23:11 UTC

Utili

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 gen 2026, 22:55 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 gen 2026, 21:39 UTC

I principali Market Mover

Raytheon Down Following Trump Post Criticizing Company

7 gen 2026, 20:13 UTC

I principali Market Mover

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 gen 2026, 20:03 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 gen 2026, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 gen 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 gen 2026, 22:48 UTC

Discorsi di Mercato

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 gen 2026, 22:46 UTC

Utili

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 gen 2026, 22:45 UTC

Utili

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 gen 2026, 22:42 UTC

Utili

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 gen 2026, 22:40 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 gen 2026, 22:31 UTC

Discorsi di Mercato

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 gen 2026, 22:22 UTC

Discorsi di Mercato

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 gen 2026, 22:01 UTC

Discorsi di Mercato

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 gen 2026, 21:46 UTC

Discorsi di Mercato

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 gen 2026, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 gen 2026, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 gen 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 gen 2026, 20:29 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 gen 2026, 20:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 gen 2026, 19:58 UTC

Discorsi di Mercato

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 gen 2026, 19:48 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Confronto tra pari

Modifica del prezzo

Main Street Capital Corp Previsione

Obiettivo di Prezzo

By TipRanks

7.54% in crescita

Previsioni per 12 mesi

Media 65.33 USD  7.54%

Alto 70 USD

Basso 60 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Main Street Capital Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

52.6034 / 54.64Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

182 / 525 Classifica in Finanza

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Main Street Capital Corp

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations, and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies ranging between $5 million and $125 million in equity investment with annual revenues between $10 million and $150 million and EBITDA in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $150 million per transaction in debt investment value but holds the ability to lead debt financings up to $250 million and invests between $10 million and $150 million in credit solutions with EBITDA in the range of $5 million and $75 million for credit solutions. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minori
help-icon Live chat